BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Diagnosis
7 results:

  • 1. The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study.
    Andresen K; Carreira H; Strongman H; McDonald HI; Benitez-Majano S; Mansfield KE; Nitsch D; Tomlinson LA; Bhaskaran K
    BMC Cancer; 2023 Sep; 23(1):839. PubMed ID: 37679679
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Seasonal variations in the diagnosis of the top 10 cancers in Korea: A nationwide population-based study using a common data model.
    Yoon JY; Kwak MS; Kim HI; Cha JM
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3371-3380. PubMed ID: 34293206
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
    Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK
    Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Everolimus compliance and persistence among tuberous sclerosis complex patients with renal angiomyolipoma or subependymal giant cell astrocytoma.
    Song X; Said Q; Tran O; Krueger DA; Bissler J
    Curr Med Res Opin; 2019 Jun; 35(6):1103-1110. PubMed ID: 30550347
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Diagnostic value of mult-detector CT for papillary renal cell carcinoma and chromophobe renal cell carcinoma].
    Liu X; Zou X; Chen H; Fang X; Hu X; Sun R
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):52-6. PubMed ID: 25877320
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer.
    Garre P; Martín L; Bando I; Tosar A; Llovet P; Sanz J; Romero A; de la Hoya M; Díaz-Rubio E; Caldés T
    Fam Cancer; 2014 Mar; 13(1):109-19. PubMed ID: 24061861
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.
    Heng DY; Xie W; Regan MM; Harshman LC; Bjarnason GA; Vaishampayan UN; Mackenzie M; Wood L; Donskov F; Tan MH; Rha SY; Agarwal N; Kollmannsberger C; Rini BI; Choueiri TK
    Lancet Oncol; 2013 Feb; 14(2):141-8. PubMed ID: 23312463
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.